Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network
Alice Garrett(Institute of Cancer Research), Clare Turnbull(Royal Marsden NHS Foundation Trust), Helen Hanson(University of Exeter), James Drummond(Cambridge University Hospitals NHS Foundation Trust), Rachel Robinson(Leeds Teaching Hospitals NHS Trust), Emma R. Woodward(Manchester Academic Health Science Centre), Diana Baralle(Southampton General Hospital), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Sabrina Talukdar(St George's, University of London), Lucy Side(Princess Anne Hospital), Marc Tischkowitz(University of Cambridge), Gail Norbury(Guy's and St Thomas' NHS Foundation Trust), Alison Callaway(Wessex Regional Genetics Laboratory), George J. Burghel, Andrew J. Wallace, Miranda Durkie(Sheffield Children's NHS Foundation Trust), Cankut Çubuk(Queen Mary University of London), Mary Alikian(Institute of Cancer Research), Sian Ellard(University of Exeter), D. Gareth Evans(Institute of Cancer Research), Treena Cranston(Churchill Hospital), Fiona Lalloo(Manchester University NHS Foundation Trust), Ian Berry(Leeds Teaching Hospitals NHS Trust), Diana Eccles(Princess Anne Hospital), Sheila Palmer-Smith(University Hospital of Wales)
Cited by 54
Related Papers
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
MicroRNA Related Polymorphisms and Breast Cancer Risk
|PLoS ONE|2014|638